Olaparib and somatic BRCA mutations. - Wikidata - wikimedia - TriplyDB

Olaparib and somatic BRCA mutations.

Olaparib and somatic BRCA mutations.

http://www.wikidata.org/entity/Q42343103

about

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

P2860

Q55085143-3A982157-F7CC-4C8F-ADC7-878114FA1688

P2860

Olaparib and somatic BRCA mutations.

http://www.wikidata.org/entity/Q42343103

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Olaparib and somatic BRCA mutations.

@en

Olaparib and somatic BRCA mutations.

@nl

type

label

Olaparib and somatic BRCA mutations.

@en

Olaparib and somatic BRCA mutations.

@nl

prefLabel

Olaparib and somatic BRCA mutations.

@en

Olaparib and somatic BRCA mutations.

@nl

P1433

Q42343103-545904AA-2AD9-4DD9-995D-86BA03354618

P1476

Q42343103-A004ECB4-0919-449B-ACA0-E8B7B00FAF1A

P2093

Q42343103-072B6728-8D25-499C-90D3-CD9515A627F4

Q42343103-4B05DA96-1A28-441B-BF9D-69755A575308

Q42343103-CCCF0110-4C37-4545-A5D5-FBF5FB7AFB49

P2860

Q42343103-8C83295E-4C7D-45E3-8BA4-D1B350596B7E

Q42343103-AFFF7092-F7DB-4FFF-BACB-DAF577E2384A

Q42343103-D540E03E-F80F-4123-8CA7-04BD04F2F520

Q42343103-E5F7CD4A-8632-4F1C-8F9C-9682779E6AA2

Q42343103-F0E51B42-C449-4994-A92A-20E1D5B858EA

Q42343103-F9E5E788-6BED-47A9-BF89-EEA47AD4AFCD

P304

Q42343103-C4D8E766-3FAE-40E8-9A11-30C5C5870A11

P31

Q42343103-CD3D5AB3-F1B5-4B54-86E1-95613DB50E41

P356

Q42343103-B9C2DFC0-A045-418E-B352-0510919CE251

P407

Q42343103-9E09FC33-65E4-4544-814F-EC7A3D713222

P433

Q42343103-3481AB58-EFE6-46FB-9BA6-7EA75283EFAB

P478

Q42343103-E5BB10E5-DB05-4DD3-BC78-A8500D44C468

P577

Q42343103-B602A784-5409-4C45-886C-88A111125B80

P698

Q42343103-FB2A0107-DC4E-459F-BE93-8276B0BCA34E

P932

Q42343103-9540DCB1-F00D-47DF-AB4D-7140D932711E

P356

ONCOTARGET.18419

P1433

P1476

Olaparib and somatic BRCA mutations.

@en

P2093

Angela George

http://www.w3.org/2001/XMLSchema#string

Stan Kaye

http://www.w3.org/2001/XMLSchema#string

Susana Banerjee

http://www.w3.org/2001/XMLSchema#string

P2860

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer.

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.

P304

43598-43599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18419

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28611314

http://www.w3.org/2001/XMLSchema#string

P932

5546426

http://www.w3.org/2001/XMLSchema#string